期刊
CLINICAL RESEARCH IN CARDIOLOGY
卷 104, 期 4, 页码 304-309出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00392-014-0781-4
关键词
Heart failure; Economics; Cost-utility; Cost-effectiveness
资金
- Competence Network of Heart Failure - Federal Ministry of Education and Research (BMBF) [01GI0205/23]
Non-pharmacological treatment programmes are being developed, in which specialised nurses take care of heart failure (HF) patients. Such disease management programmes might increase survival and quality of life in HF patients, but evidence on their cost-effectiveness remains limited. A prospective economic evaluation piggy-backed onto the randomised controlled Interdisciplinary Network for Heart Failure (INH) Study weighted costs of the intervention HeartNetCare -HF (TM) (HNC) regarding effectiveness, mortality and quality-adjusted life years (QALYs). To consider uncertainty sensitivity analyses were performed. Compared to usual care (UC), HNC revealed 8,284 a,not sign per death avoided within the 6 month study follow-up period. The cost-utility analysis showed additional costs of 49,335 a,not sign per QALY. Although HNC did not reduce short-term re-admission rates of HF patients hospitalised for cardiac decompensation within the first 180 days after discharge, HNC might reduce mortality and increase quality of life in these patients at reasonable costs. Therefore, long-term HNC-effects deserve further evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据